Linfoma no Hodgkin de células del manto con infiltración renal y glomerulopatía mesangiocapilar asociada

by Raymed Antonio Bacallao Méndez, Laura López Marín, Agustín Chong López, Betsy Llerena Ferrer, Yudit Chávez Muñoz, Yanisa de la Caridad Castillo Álvarez

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

by Simon Heine, Markus Kleih, Neus Giménez, Kathrin Böpple, German Ott, Dolors Colomer, Walter E. Aulitzky, Heiko van der Kuip, Elisabeth Silkenstedt
Published 2018-09-01

The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma...

by Kamil D. Kaplanov
Published 2021-08-01

Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report

by Maximilian Higer, Denis Cana, Juergen Podlech, Simin Schadmand-Fischer, Andreas Schwarting, Daniel Teschner, Matthias Theobald, Thomas Wölfel, Georg Hess
Published 2020-08-01

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy

by Yang C, Lei W, Xie H, Wu G, Wei J, Liang A, Qian W
Published 2020-11-01

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network

by Daniela Drandi, Marion Alcantara, Ichrafe Benmaad, Arian Söhlbrandt, Ludovic Lhermitte, GianMaria Zaccaria, Martina Ferrante, Elisa Genuardi, Barbara Mantoan, Patrick Villarese, Morgane Cheminant, Irene della Starza, Elena Ciabatti, Riccardo Bomben, Cristina Jimenez, Mary Callanan, Chrystelle Abdo, Cornelia Eckert, Vincent Ribrag, Sergio Cortelazzo, Martin Dreyling, Olivier Hermine, Marie-Hélène Delfau-Larue, Christiane Pott, Marco Ladetto, Simone Ferrero, Elizabeth Macintyre
Published 2020-04-01

ACUTE RENAL FAILURE DUE TO MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND TUMORAL CELL INFILTRATION IN A PATIENT WITH MANTLE CELL LYMPHOMA: A CASE REPORT

by Maria Julia Montoro, Elias Alejandro Jatem, Pau Abrisqueta, Nerea Castillo, Maria Teresa Salcedo, Josepa Vila
Published 2014-08-01

Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.

by Zheng Chen, Eric F Pittman, Jorge Romaguera, Luis Fayad, Michael Wang, Sattva S Neelapu, Peter McLaughlin, Larry Kwak, Nami McCarty
Published 2013-01-01

Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

by VI Vorob’ev, VA Zherebtsova, EI Dubrovin, LA Bychenkova, YuB Kochkareva, LA Mukha, VL Ivanova, NK Khuazheva, VV Ptushkin
Published 2019-03-01

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States

by Shaum M. Kabadi, Aimee Near, Keiko Wada, Chakkarin Burudpakdee
Published 2019-12-01

De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly

by Ghaleb Elyamany, Ali Matar Alzahrani, Eman Al Mussaed, Hassan Aljasem, Sultan Alotaibi, Hatem Elghezal
Published 2015-01-01

Molecular diagnosis of malignant lymphoma : mantle cell lymphoma, anaplastic large cell lymphoma, and marginal zone B-cell lymphoma of malt

by Sakakibaya, Ayako, Kawai, Kumi, Nagasaka, Tetsuro, Nakamura, Shigeo, 下山, 芳江, 榊原, 綾子, 川井, 久美, 長坂, 徹郎
Published 2006

Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation

by Galliano Marco, Franco Pierfrancesco, Filippi Andrea, Ricardi Umberto
Published 2006-09-01

Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential

by Olga Kersy, Mali Salmon-Divon, Ofer Shpilberg, Oshrat Hershkovitz-Rokah
Published 2021-08-01

Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI

by Paul J. Akhenblit PhD, Neale T. Hanke PhD, Alexander Gill BS, Daniel O. Persky MD, Christine M. Howison MS, Mark D. Pagel PhD, Amanda F. Baker PharmD, PhD
Published 2016-04-01

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

by Fehmi Hindilerden, İpek Yönal Hindilerden, Reyhan Diz Küçükkaya
Published 2021-03-01

MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway

by Yuan J, Zhang Q, Wu S, Yan S, Zhao R, Sun Y, Tian X, Zhou K
Published 2021-03-01

Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib Treatment

by Viktoria Fuhr, Ehsan Vafadarnejad, Oliver Dietrich, Panagiota Arampatzi, Angela Riedel, Antoine-Emmanuel Saliba, Andreas Rosenwald, Hilka Rauert-Wunderlich
Published 2021-02-01

Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

by Jessica D. Rich, Stephen M. Clark, Yuri Fedoriw, Valerie Jewells, William Wood, Christopher Dittus
Published 2019-10-01

Blastoid variant of mantle cell lymphoma of the female urethra mimicking a caruncle: A rare but highly aggressive subtype case with literature review

by Franco Palmisano, Vito Lorusso, Matteo Giulio Spinelli, Paolo Guido Dell'Orto, Emanuele Montanari
Published 2019-03-01